261
Participants
Start Date
March 31, 2008
Primary Completion Date
November 30, 2008
Study Completion Date
December 31, 2008
irbesartan
300 mg (2 x 150 mg capsules) once daily for 12 weeks
placebo
placebo capsules once daily for 12 weeks
PS433540
200 mg (2 x 100 mg capsules) once daily for 12 weeks
PS433540
400 mg (4 x 100 mg capsules) once daily for 12 weeks
PS433540
800 mg (8 x 100 mg capsules) once daily for 12 weeks
Brandywine Clinical Research Center, Downingtown
MD Medical Research, Oxon Hill
Hampton Roads Center for Clinical Research, Norfolk
Peidmont Medical Research Associates, Winston-Salem
Cary Medical Research, Cary
Triangle Medical Research NC, Raleigh
Crescent Medical Research, Salisbury
Metrolina Medical Research, Charlotte
New Hanover Medical Rersearch, Wilmington
Unifour Medical Research NC, Hickory
Northstate Clinical Research, Lenoir
Q Clinical Research, Decatur
Clinical Research Atlanta, Stockbridge
Jacksonville Center for Clinical Research, Jacksonville
Univ. Clinical Research Deland, LLC., DeLand
North County Medical, Sebastian
Allan Graff, Fort Lauderdale
Advanced Clinical Research 1000 Forrest Place Suite 2 Pell City, Pell City
Delaware Smith Clinic, Delaware
Smith Clinic, Marion
The Lindner Center, Cincinnati
Midwest Institute for Clinical Research, Indianapolis
Gemini Scientific LLC, Madison
Cedar Crosse Research Center, Chicago
COR Clinical Research, L.L.C, Oklahoma City
Punzi Medical Center, Carrollton
Innovative Clinical Trials, San Antonio
IMED Research PA, San Antonio
Premiere Pharmaceutical Research, LLC, Tempe
Genova Clinical Research AZ, Tucson
National Research Institute, Los Angeles
Associated Pharmaceutical Research Center, Buena Park
Long Beach Center for Clinical Research, Long Beach
Westlake Medical Center, Westlake Village
Orange County Research Center, Tustin
Advanced Clinical Research Institute, Anaheim
Clinical Trials Research CA, Lincoln
Superior Regional Research, LLC, Sacramento
East-West Medical Research Institute, Honolulu
Hypertension & Nephrology Inc, Providence
Lead Sponsor
Ligand Pharmaceuticals
INDUSTRY